世界のびまん性大細胞型B細胞リンパ腫（DLBCL）治療薬市場は、予測期間中に約7.71 %のCAGRで推移し、2022年から2026年の間に17億9,000万USドルの成長が見込まれています。本レポートは、総体的な分析、市場規模と予測、動向、成長推進要因、課題、および約25社のベンダーを対象とするベンダー分析を提供しています。
本レポートは、現在の世界市場シナリオ、最新動向と成長推進要因、および全体的な市場環境に関する最新の分析を提供します。市場を牽引しているのは、高齢者人口の増大、びまん性大細胞型B細胞リンパ腫（DLBCL）の発症率の上昇、再発性・難治性のびまん性大細胞型B細胞リンパ腫（DLBCL）患者への治療薬承認の増加です。
本調査では、技術の進歩が今後数年間のびまん性大細胞型B細胞リンパ腫（DLBCL）治療薬市場の成長を促進する主要な理由の1つであると特定しています。また、患者支援プログラムの増加や戦略的提携は、市場の大きな需要につながるでしょう。
TechNavio社の堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、主要なびまん性大細胞型B細胞リンパ腫（DLBCL）治療薬市場ベンダーの詳細な分析を提供します
この調査は、業界の主要な参加者からの情報を含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加えて、包括的な市場とベンダー情勢が含まれています。
TechNavio社は、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析により、複数のソースからのデータの調査、統合、および集計により、市場の詳細な状況を提示します。また、業界の主要なインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは、包括的で信頼性が高く、一次および二次の広範な調査の結果です。TechNavio社の市場調査レポートは、完全な競争環境と、質的および量的調査を使用して正確な市場成長を予測する詳細なベンダー選択の調査手法と分析を提供します。
目次
Table of Contents
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Product
5.1 Market segments
Exhibit 24: Chart on Product - Market share 2021-2026 (%)
Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
5.2 Comparison by Product
Exhibit 26: Chart on Comparison by Product
Exhibit 27: Data Table on Comparison by Product
5.3 Small molecules - Market size and forecast 2021-2026
Exhibit 28: Chart on Small molecules - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Small molecules - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Small molecules - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Small molecules - Year-over-year growth 2021-2026 (%)
5.4 Biologics - Market size and forecast 2021-2026
Exhibit 32: Chart on Biologics - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Biologics - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Biologics - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Biologics - Year-over-year growth 2021-2026 (%)
5.5 Market opportunity by Product
Exhibit 36: Market opportunity by Product ($ million)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 UK - Market size and forecast 2021-2026
Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.10 China - Market size and forecast 2021-2026
Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
7.11 Canada - Market size and forecast 2021-2026
Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 78: Market opportunity By Geographical Landscape ($ million)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 79: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 81: Overview on factors of disruption
9.4 Industry risks
Exhibit 82: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 83: Vendors covered
10.2 Market positioning of vendors
Exhibit 84: Matrix on vendor position and classification
10.3 AbbVie Inc.
Exhibit 85: AbbVie Inc. - Overview
Exhibit 86: AbbVie Inc. - Product / Service
Exhibit 87: AbbVie Inc. - Key offerings
10.4 Amgen Inc.
Exhibit 88: Amgen Inc. - Overview
Exhibit 89: Amgen Inc. - Product / Service
Exhibit 90: Amgen Inc. - Key offerings
10.5 Bayer AG
Exhibit 91: Bayer AG - Overview
Exhibit 92: Bayer AG - Business segments
Exhibit 93: Bayer AG - Key offerings
Exhibit 94: Bayer AG - Segment focus
10.6 BeiGene Ltd.
Exhibit 95: BeiGene Ltd. - Overview
Exhibit 96: BeiGene Ltd. - Business segments
Exhibit 97: BeiGene Ltd. - Key offerings
Exhibit 98: BeiGene Ltd. - Segment focus
10.7 Erytech PharmaSA
Exhibit 99: Erytech PharmaSA - Overview
Exhibit 100: Erytech PharmaSA - Product / Service
Exhibit 101: Erytech PharmaSA - Key offerings
10.8 F. Hoffmann La Roche Ltd.
Exhibit 102: F. Hoffmann La Roche Ltd. - Overview
Exhibit 103: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 104: F. Hoffmann La Roche Ltd. - Key news
Exhibit 105: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 106: F. Hoffmann La Roche Ltd. - Segment focus
10.9 Merck and Co. Inc.
Exhibit 107: Merck and Co. Inc. - Overview
Exhibit 108: Merck and Co. Inc. - Business segments
Exhibit 109: Merck and Co. Inc. - Key news
Exhibit 110: Merck and Co. Inc. - Key offerings
Exhibit 111: Merck and Co. Inc. - Segment focus
10.10 Novartis AG
Exhibit 112: Novartis AG - Overview
Exhibit 113: Novartis AG - Business segments
Exhibit 114: Novartis AG - Key offerings
Exhibit 115: Novartis AG - Segment focus
10.11 Pfizer Inc.
Exhibit 116: Pfizer Inc. - Overview
Exhibit 117: Pfizer Inc. - Product / Service
Exhibit 118: Pfizer Inc. - Key news
Exhibit 119: Pfizer Inc. - Key offerings
10.12 Spectrum Pharmaceuticals Inc.
Exhibit 120: Spectrum Pharmaceuticals Inc. - Overview
Exhibit 121: Spectrum Pharmaceuticals Inc. - Product / Service
Exhibit 122: Spectrum Pharmaceuticals Inc. - Key news
Exhibit 123: Spectrum Pharmaceuticals Inc. - Key offerings
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 124: Inclusions checklist
Exhibit 125: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 126: Currency conversion rates for US$
11.4 Research methodology
Exhibit 127: Research methodology
Exhibit 128: Validation techniques employed for market sizing
Exhibit 129: Information sources
11.5 List of abbreviations
Exhibit 130: List of abbreviations
Exhibits
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Product - Market share 2021-2026 (%)
Exhibits25: Data Table on Product - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Product
Exhibits27: Data Table on Comparison by Product
Exhibits28: Chart on Small molecules - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Small molecules - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Small molecules - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Small molecules - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Biologics - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Biologics - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Biologics - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Biologics - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Product ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: AbbVie Inc. - Overview
Exhibits86: AbbVie Inc. - Product / Service
Exhibits87: AbbVie Inc. - Key offerings
Exhibits88: Amgen Inc. - Overview
Exhibits89: Amgen Inc. - Product / Service
Exhibits90: Amgen Inc. - Key offerings
Exhibits91: Bayer AG - Overview
Exhibits92: Bayer AG - Business segments
Exhibits93: Bayer AG - Key offerings
Exhibits94: Bayer AG - Segment focus
Exhibits95: BeiGene Ltd. - Overview
Exhibits96: BeiGene Ltd. - Business segments
Exhibits97: BeiGene Ltd. - Key offerings
Exhibits98: BeiGene Ltd. - Segment focus
Exhibits99: Erytech PharmaSA - Overview
Exhibits100: Erytech PharmaSA - Product / Service
Exhibits101: Erytech PharmaSA - Key offerings
Exhibits102: F. Hoffmann La Roche Ltd. - Overview
Exhibits103: F. Hoffmann La Roche Ltd. - Business segments
Exhibits104: F. Hoffmann La Roche Ltd. - Key news
Exhibits105: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits106: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits107: Merck and Co. Inc. - Overview
Exhibits108: Merck and Co. Inc. - Business segments
Exhibits109: Merck and Co. Inc. - Key news
Exhibits110: Merck and Co. Inc. - Key offerings
Exhibits111: Merck and Co. Inc. - Segment focus
Exhibits112: Novartis AG - Overview
Exhibits113: Novartis AG - Business segments
Exhibits114: Novartis AG - Key offerings
Exhibits115: Novartis AG - Segment focus
Exhibits116: Pfizer Inc. - Overview
Exhibits117: Pfizer Inc. - Product / Service
Exhibits118: Pfizer Inc. - Key news
Exhibits119: Pfizer Inc. - Key offerings
Exhibits120: Spectrum Pharmaceuticals Inc. - Overview
Exhibits121: Spectrum Pharmaceuticals Inc. - Product / Service
Exhibits122: Spectrum Pharmaceuticals Inc. - Key news
Exhibits123: Spectrum Pharmaceuticals Inc. - Key offerings
Exhibits124: Inclusions checklist
Exhibits125: Exclusions checklist
Exhibits126: Currency conversion rates for US$
Exhibits127: Research methodology
Exhibits128: Validation techniques employed for market sizing
Exhibits129: Information sources
Exhibits130: List of abbreviations
